FDA Approvals - Cancer Currents Blog
News on recent approvals of cancer therapies by the Food and Drug Administration. Includes expert comments on how the approval will influence patient care and future research.
-
FDA Approves First Immunotherapy Treatment for Lung CancerThe FDA has approved nivolumab to treat patients with advanced non-small cell lung cancer that has progressed during or after treatment with platinum-based chemotherapy.
-
FDA Approves Panobinostat for Some Patients with Multiple MyelomaThe FDA granted accelerated approval of panobinostat for the treatment of multiple myeloma that has progressed after at least two prior standard therapies.
-
FDA Approves Lenvatinib for Radioactive Iodine-Refractory Thyroid CancerThe FDA has approved lenvatinib (Lenvima) to treat some patients with the most common type of thyroid cancer.
-
FDA Grants Palbociclib Accelerated Approval for Advanced Breast CancerPalbociclib (Ibrance) is approved to be used in combination with letrozole (Femara) to treat postmenopausal women with metastatic breast cancer.
-
A Good Year: FDA Approved Nine New Cancer Drugs in 2014In 2014, the Food and Drug Administration (FDA) approved 41 drugs that had not been approved previously for any indication, the most in nearly 20 years. Of these 41 novel drugs, 9 were approved for the treatment of cancer or cancer-related conditions.